Explore 3 Stock Ideas & Industry Insights Download Free Report
Electromed, Inc. (NYSE American: ELMD) was a notable name on Top Gaining US Stocks screener for 13 May 2026. The screener recorded a single-session change of 25.11% to USD 34.03, with reported volume of 227.53 thousand shares — 5.81 times the stock's typical activity.
Key Highlights
The obesity treatment market has been transformed over the past three years. Semaglutide — marketed as Wegovy for weight management and Ozempic for type 2 diabetes — has become the defining pharmaceutical story of the decade. But Novo Nordisk is not standing still. Data …
Introduction: Why May 2026 Is a Landmark Month for the Biotech Pipeline
On May 13, 2026, Assembly Biosciences (Nasdaq:ASMB) announced that topline Phase 1a clinical data on ABI-6250, its investigational oral hepatitis D virus entry inhibitor, will be presented at the European Association for the Study of the Liver Congress in Barcelona later this month.
Clinical Context: Why the Transition Question Matters
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!